Your session is about to expire
Zegerid vs Pepcid
Introduction
For patients who experience gastroesophageal reflux disease (GERD) or other forms of indigestion, there are certain medications that help manage the production and effects of stomach acid. Zegerid and Pepcid are two such drugs often used as a form of treatment. Though both are designed to address digestive issues, they each interact differently with your body's physiological processes. Zegerid is a proton pump inhibitor (PPI), meaning it works by directly blocking the enzyme system that produces stomach acid. On the other hand, Pepcid falls under the category of H2 blockers, which act by obstructing histamine receptors in your stomach lining—resulting in decreased production of stomach acid over time.
Zegerid vs Pepcid Side By Side
| Attribute | Zegerid | Pepcid |
|---|---|---|
| Brand Name | Zegerid | Pepcid |
| Contraindications | Should not be taken with atazanavir or nelfinavir. Prolonged use may increase risk for bone fractures. | Should not be taken with atazanavir or nelfinavir. May cause confusion in elderly patients with severely impaired renal function. |
| Cost | Brand-name: around $230 for 42 tablets (20 mg), Generic: around $30 - 60/month | Brand-name: about $17 for 30 tablets (10 mg), Generic: approximately $4 up to around $15/month |
| Generic Name | omeprazole/sodium bicarbonate | famotidine |
| Most Serious Side Effect | Signs of an allergic reaction, kidney problems, severe stomach pain, unusual changes in mood or behavior, new signs of a lupus-like syndrome, low magnesium levels. | Serious allergic reaction, irregular heartbeat, visual disturbances, unusual changes in mood or behavior, skin reactions. |
| Severe Drug Interactions | Atazanavir, nelfinavir | Atazanavir, nelfinavir |
| Typical Dose | 20–40 mg/day on an empty stomach at least one hour before a meal | 20 mg taken orally twice daily, can be increased to 40 mg/day |
What is Zegerid?
Zegerid (omeprazole/sodium bicarbonate) and Pepcid (famotidine) are both medications used to treat gastroesophageal reflux disease, commonly known as GERD, but they belong to different classes of drugs. Zegerid is a proton pump inhibitor first approved by the FDA in 2004. It works by reducing the production of stomach acid, providing long-lasting relief from heartburn and other symptoms associated with GERD. This makes it particularly effective for those who need continuous treatment.
On the other hand, Pepcid belongs to a class of drugs called histamine-2 blockers. Famotidine blocks the action of histamine on stomach cells, thus reducing production of stomach acid. Although not as potent or long-lasting as Zegerid, famotidine acts more quickly and is often used for treating acute symptoms rather than long-term management.
Both drugs have fewer side effects compared to older treatments due their specific modes of action; however each medication may come with its own set of potential adverse reactions that patients should discuss thoroughly with their healthcare provider before use.
What conditions is Zegerid approved to treat?
Zegerid is approved for the treatment of several different acid-related conditions:
- Gastroesophageal reflux disease (GERD)
- Gastric and duodenal ulcers
- Prevention of stomach ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs)
- Zollinger-Ellison syndrome, a rare condition where the stomach produces too much acid.
How does Zegerid help with these illnesses?
Zegerid aids in managing gastroesophageal reflux disease (GERD) and stomach ulcers by reducing the production of acid in the stomach. It achieves this by blocking an enzyme on the surface of stomach lining cells that is responsible for secreting gastric acid. Gastric acid plays a significant role in digestion, but excessive amounts can lead to conditions such as GERD or peptic ulcer disease. Individuals with these conditions have relatively higher levels of gastric acid. Therefore, by decreasing gastric acid production, Zegerid helps limit the negative effects of excessive acidity and allows patients to manage their condition more effectively.
On the other hand, Pepcid works slightly differently; it blocks histamine at H2-receptors located primarily on gastric parietal cells preventing gastrin-stimulated secretion of HCI (hydrochloric acid). Like Zegerid, it also reduces acidity in the stomach aiding those with similar gastrointestinal issues. However, choosing between them depends on individual patient needs and medical history as both have their own unique pharmacological profiles and potential side effects.
What is Pepcid?
Pepcid, known generically as famotidine, is an H2 histamine receptor antagonist that inhibits the production of stomach acid. Famotidine was first approved by the FDA in 1986 and is available over-the-counter or by prescription depending on its strength.
It operates by blocking one type of receptor for histamine (the H2 receptors) and thus significantly reduces the secretion of stomach acid. As Pepcid does not have an effect on proton pumps, it has a different side-effect profile to PPIs such as Zegerid.
Its lack of action on proton pumps means that unlike Proton Pump Inhibitors (PPIs), it doesn't completely block production of stomach acid. This can make it less effective than PPIs like Zegerid for certain conditions where complete suppression of stomach acid is desired. However, this may also result in fewer long-term risks associated with significant reduction in gastric acidity levels which are seen with prolonged use of PPIs like Zegerid.
What conditions is Pepcid approved to treat?
Pepcid is a trusted medication that has been approved for the treatment of:
- Gastroesophageal reflux disease (GERD, also known as "acid reflux")
- Gastric and duodenal ulcers
- Conditions where the stomach produces too much acid, such as Zollinger-Ellison syndrome.
How does Pepcid help with these illnesses?
Histamine is a compound that is released by cells in response to injury and allergic and inflammatory reactions, causing contraction of smooth muscle and dilation of capillaries. It plays a significant role in stimulating acid production in the stomach. Pepcid works by blocking the action of histamine on the stomach cells, thereby reducing the production of acid. This alleviates symptoms associated with conditions such as gastroesophageal reflux disease (GERD) or peptic ulcers. Its action on gastric mucosa may also play roles in its effectiveness as an antacid treatment. Since it does not affect bicarbonate levels significantly, it is sometimes prescribed when a patient does not respond well to proton pump inhibitors like Zegerid or can be combined with other treatments for more efficient relief from heartburn symptoms.
How effective are both Zegerid and Pepcid?
Both Zegerid and Pepcid have proven to be successful in treating patients with gastroesophageal reflux disease (GERD), peptic ulcers, and other conditions caused by excess stomach acid. They were approved by the FDA only a few years apart, with Zegerid receiving approval in 2004 and Pepcid earlier in 1986. Since they act differently on stomach acid production, they may be prescribed under different circumstances.
Zegerid is a combination medication that includes omeprazole and sodium bicarbonate. Omeprazole belongs to a class of drugs known as proton pump inhibitors (PPIs) which work by reducing the amount of acid your stomach produces. Sodium bicarbonate is an antacid that reduces stomach acid.
Pepcid contains famotidine which belongs to a family of medications known as histamine-2 blockers. It works by reducing the amount of acid produced by the cells in your stomach lining.
A direct comparison between Zegerid and Pepcid was made during trials studying their effectiveness at alleviating symptoms related to GERD; both drugs exhibited similar efficacy levels alongside comparable safety profiles. In these studies, no significant differences were found concerning symptom relief between patients who received Zegerid or those treated with Pepcid.
In terms of side effects, both medications are generally well-tolerated but can occasionally cause constipation, diarrhea or headaches among other potential side effects. However, long-term use or overuse can lead to more serious problems such as vitamin B12 deficiency or kidney issues for both medicines.
Nonetheless due to its pharmacology combining two active ingredients acting on two different mechanisms - one immediate and one prolonged - Zegerid might offer advantages especially where rapid relief from heartburn is desired along with sustained control over gastric acidity.
Related trials for zegerid and pepcid
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Zegerid typically prescribed?
Oral dosages of Zegerid range from 20–40 mg/day, each dose to be taken on an empty stomach at least one hour before a meal. For most people with gastroesophageal reflux disease (GERD), a daily dose of 20 mg is sufficient. However, for those with more severe conditions like erosive esophagitis, the dosage can be increased to 40 mg/day after initial treatment if there is no response. On the other hand, Pepcid's suggested usage varies between 10-20mg taken once or twice per day depending upon severity and type of condition being treated; it does not need to be taken on an empty stomach. Both medications should not exceed the maximum recommended dosage unless instructed by a healthcare provider.
At what dose is Pepcid typically prescribed?
Pepcid treatment is typically initiated at a dose of 20 mg taken orally twice daily. The dosage can then be increased to 40 mg/day, divided into two doses and spaced approximately 12 hours apart. For the management of conditions such as Zollinger-Ellison syndrome, the maximum dose is 240 mg per day which should be divided into multiple doses throughout the day. This higher regimen may be explored if there's no noticeable improvement in symptoms after several weeks on the standard dosage plan.
What are the most common side effects for Zegerid?
Common side effects of Zegerid can include:
- Headache
- Abdominal pain
- Diarrhea or constipation
- Nausea, vomiting, or gas
- Dizziness
- Upper respiratory tract infection symptoms (like a cold)
- Acid regurgitation
On the other hand, Pepcid users may experience:
- Constipation or diarrhea
- Fatigue
-Dizziness
-Mood changes
-Nausea and vomiting
-Swelling due to fluid retention
-Joint pain
Remember that this is not an exhaustive list and other side effects may occur. Always consult with your healthcare provider for medical advice about side effects.
Are there any potential serious side effects for Zegerid?
While Zegerid is generally well-tolerated, it may cause side effects in rare cases. These can include:
- Signs of an allergic reaction such as hives, difficulty breathing, swelling of your face or throat
- Symptoms related to kidney problems: blood in your urine, little or no urinating; painful or difficult urination; swelling in your feet or ankles; feeling tired
- Severe stomach pain
- Unusual changes in mood or behavior - agitation, confusion, depression, hallucinations
- New signs of a lupus-like syndrome - joint pain and/or rash on cheeks and arms that worsens under sunlight.
- Low magnesium levels – dizziness and fast heartbeats with shortness of breath.
If you experience any serious symptoms while taking Zegerid such as those above, it's imperative that you seek immediate medical attention.
What are the most common side effects for Pepcid?
The side effects of Pepcid can include:
- Headache
- Dizziness or drowsiness
- Constipation or diarrhea
- Nausea, vomiting, and stomach discomfort
- Decreased sexual ability (in men) -A change in the amount of urine -Swollen tongue -Dry mouth or throat
In rare cases, it can also cause a fast or slow heartbeat, mood changes such as restlessness and confusion. Always consult your healthcare provider to ensure you understand all potential side effects when choosing between Zegerid and Pepcid.
Are there any potential serious side effects for Pepcid?
While Pepcid is typically well-tolerated, it's vital to be aware of potential severe side effects that can occur in rare cases. These may include:
- Signs of a serious allergic reaction, such as trouble breathing or swallowing, hives, swelling in your face or throat
- An irregular heartbeat or heart rate that's unusually fast or slow
- Visual disturbances like blurred vision and seeing halos around lights
- Unusual changes in mood or behavior including confusion
- Skin reactions: This could include a painful skin rash that spreads and causes blistering and peeling.
If you notice any of these symptoms while taking Pepcid, immediately seek medical attention.
Contraindications for Zegerid and Pepcid?
Both Zegerid and Pepcid, like most other medications for gastroesophageal reflux disease (GERD) and stomach ulcers, may have side effects. If you notice worsening of any symptoms such as heartburn, difficulty swallowing or persistent nausea/vomiting, please seek immediate medical attention.
Neither Zegerid nor Pepcid should be taken if you are taking certain types of drugs such as atazanavir or nelfinavir. Always inform your healthcare provider which medications you're currently on; these particular drugs can interact negatively with both Zegerid and Pepcid because they depend on a certain level of acidity in the stomach to be absorbed into the body properly.
In addition, prolonged use of proton pump inhibitors like Zegerid might increase your risk for bone fractures especially if you take it more than a year, or take high doses. On the other hand, H2 blockers like Pepcid could cause confusion especially in elderly patients who have severely impaired renal function.
How much do Zegerid and Pepcid cost?
For the brand-name versions of these drugs:
- The price of 42 tablets of Zegerid (20 mg) averages around $230, which works out to approximately $5.50/day.
- The price for 30 Pepcid (10 mg) tablets is about $17, working out to roughly $0.57/day.
This means if you are taking a standard dose of one tablet per day, Pepcid is significantly less expensive than Zegerid on a per-day treatment basis. Remember that cost should only be one factor in your decision and efficacy and tolerability are crucial considerations too.
On the other hand, comparing generic versions:
- Omeprazole/sodium bicarbonate (generic for Zegerid) costs can vary greatly but average at around $1 - $2 per pill or about $30 - 60/month.
- Famotidine (generic for Pepcid), is also cheaper with an average monthly cost ranging from as low as approximately $4 up to around $15 depending on retailer pricing variations.
Popularity of Zegerid and Pepcid
Zegerid, a combination of omeprazole and sodium bicarbonate, was estimated to have been prescribed to about 1.7 million people in the US in 2020. Zegerid accounted for just over 3% of proton pump inhibitor prescriptions in the US. However, it appears to be one of the few "hybrid" antacids (a combination of acid suppressor and buffer). The use of Zegerid has been generally stable since its introduction.
Famotidine, including brand versions such as Pepcid, was prescribed to around 3 million people in the USA in 2020. In terms of H2 antagonist prescriptions, famotidine accounts for just under 38%. Overall within gastric acid reducer prescriptions, it holds approximately an 8% share. The prevalence of famotidine has seen a considerable increase over the last few years due mainly to concerns surrounding ranitidine recalls.
Conclusion
Both Zegerid (omeprazole/sodium bicarbonate) and Pepcid (famotidine) are widely used in the management of conditions related to excess stomach acid, such as gastroesophageal reflux disease (GERD), ulcers, and heartburn. They have been backed by extensive clinical studies and meta-analyses demonstrating their effectiveness over placebo treatments. In some instances, these medications may be combined if deemed necessary by a healthcare provider.
Zegerid primarily works as a proton pump inhibitor which blocks the production of stomach acid at its source whereas Pepcid acts as an H2 antagonist which inhibits one pathway of acid production. Thus, they tend to be prescribed under different circumstances - Zegerid is often considered first-line treatment for GERD while Pepcid may be chosen for immediate relief or prevention of heartburn symptoms associated with indigestion and sour stomach.
Both medications are available in generic form representing significant cost savings especially for patients who must pay out-of-pocket costs. An adjustment period might be needed when starting either medication since effects may not be noticeable immediately.
The side effect profiles between these two drugs are generally similar with most common ones being headache, diarrhea or constipation; however, long-term use of proton pump inhibitors like Zegerid has been linked to increased risks including kidney issues and certain infections compared to H2 antagonists like Pepcid. Therefore it's important that patients closely monitor any changes in health status when starting treatment with either drug.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Orbelo, D. M., Enders, F. T., Romero, Y., Francis, D. L., Achem, S. R., Dabade, T. S., … Katzka, D. A. (2014, January 22). Once-Daily Omeprazole/Sodium Bicarbonate Heals Severe Refractory Reflux Esophagitis with Morning or Nighttime Dosing. Digestive Diseases and Sciences. Springer Science and Business Media LLC.http://doi.org/10.1007/s10620-013-3017-y
- Loffredo, M., Lucero, H., Chen, D.-Y., O’Connell, A., Bergqvist, S., Munawar, A., … Munawar, A. H. (2021, March 8). The in-vitro effect of famotidine on SARS-CoV-2 proteases and virus replication. Scientific Reports. Springer Science and Business Media LLC.http://doi.org/10.1038/s41598-021-84782-w
- Kromer, W., Horbach, S., & Lühmann, R. (1999). Relative Efficacies of Gastric Proton Pump Inhibitors: Their Clinical and Pharmacological Basis. Pharmacology. S. Karger AG.http://doi.org/10.1159/000028306
- Metz, D. C., Soffer, E., Forsmark, C. E., Cryer, B., Chey, W., Bochenek, W., & Pisegna, J. R. (2003, February). Maintenance oral pantoprazole therapy is effective for patients with Zollinger-Ellison syndrome and idiopathic hypersecretion. The American Journal of Gastroenterology. Ovid Technologies (Wolters Kluwer Health).http://doi.org/10.1111/j.1572-0241.2003.07262.x
- Kung, Y.-M., Hsu, W.-H., Wu, M.-C., Wang, J.-W., Liu, C.-J., Su, Y.-C., … Wang, Y.-K. (2017, November 6). Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease. Digestive Diseases and Sciences. Springer Science and Business Media LLC.http://doi.org/10.1007/s10620-017-4830-5
- Wada, T., Sasaki, M., Kataoka, H., Tanida, S., Itoh, K., Ogasawara, N., … Itoh, M. (2005, June). Efficacy of famotidine and omeprazole in healing symptoms of non‐erosive gastro‐oesophageal reflux disease: randomized‐controlled study of gastro‐oesophageal reflux disease. Alimentary Pharmacology & Therapeutics. Wiley.http://doi.org/10.1111/j.1365-2036.2005.02467.x
- Berlin, R. G., Clineschmidt, B. V., & Majka, J. A. (1986, October). Famotidine: An appraisal of its mode of action and safety. The American Journal of Medicine. Elsevier BV.http://doi.org/10.1016/0002-9343(86)90594-2